Gemma Coleman, a 37-year-old cancer survivor, shares her raw journey through ovarian and womb cancer — a battle that ended her dream of motherhood but ignited her mission to support groundbreaking research. Diagnosed in 2022 with two primary cancers, she endured grueling surgeries and chemotherapy, now living in remission for three years while managing chronic pain and fatigue. Her story underscores the emotional toll of aggressive cancer and the urgent need for better treatments. Thanks to a $2.5 million grant from Cancer Research UK, scientists at The University of Manchester are unlocking why high-grade serous ovarian cancers resist current therapies — paving the way for personalized, next-generation drugs. Gemma’s hope is clear: research isn’t just about survival — it’s about rebuilding lives, one breakthrough at a time.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
